AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 247: E585-E591, 1984;
0193-1849/84 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leshin, L. S.
Right arrow Articles by Malven, P. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leshin, L. S.
Right arrow Articles by Malven, P. V.

AJP - Endocrinology and Metabolism, Vol 247, Issue 5 585-E591, Copyright © 1984 by American Physiological Society

ARTICLES

Bacteremia-induced changes in pituitary hormone release and effect of naloxone

L. S. Leshin and P. V. Malven

Acute bacteremia in sheep caused a surge of plasma beta-endorphin/beta-lipotropin (beta-EP/beta-LPH) associated with shivering behavior, tachycardia, hyperthermia, hemoconcentration, and decreased respiration rate. The surge of plasma beta-EP/beta-LPH was immediately followed by increases (P less than 0.05) in plasma prolactin and growth hormone (GH) concentrations and a depression (P less than 0.05) of plasma luteinizing hormone. These changes in pituitary hormone release were consistent with opioid-induced changes described in the literature. To examine possible opioid mediation, naloxone (2.5 mg X kg-1 X h-1) was continuously infused intravenously from 3 h before to 3 h after induction of an E. coli bacteremia. With the exception of plasma GH, naloxone failed to alter any of the hormonal or clinical parameters associated with bacteremia. For plasma GH, naloxone delayed (P less than 0.01) the increase but did not attenuate its magnitude, suggesting that an opioid mechanism may influence the timing of the pituitary GH release resulting from bacteremia. In general, opioid mechanisms sensitive to the present dosage of naloxone do not appear to mediate bacteremia-induced changes in hormonal or clinical parameters.


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
K. Benamar, M. Yondorf, V. T. Barreto, E. B. Geller, and M. W. Adler
Deletion of {micro}-Opioid Receptor in Mice Alters the Development of Acute Neuroinflammation
J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 990 - 994.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. M. Corbacho, G. Valacchi, L. Kubala, E. Olano-Martin, B. C. Schock, T. P. Kenny, and C. E. Cross
Tissue-specific gene expression of prolactin receptor in the acute-phase response induced by lipopolysaccharides
Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E750 - E757.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. Kojima, Y. Naruse, N. Iijima, N. Wakabayashi, S. Mitsufuji, Y. Ibata, and M. Tanaka
HPA-axis responses during experimental colitis in the rat
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1348 - R1355.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online